文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

医院和重症监护病房获得性脓毒症的流行病学与负担:系统综述与Meta分析

Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis.
PubMed 文献 · Intensive Care Med · 2020-06-26
一句话结论医院获得性脓毒症占所有医院治疗脓毒症的23.6%,ICU获得性脓毒症占ICU器官功能障碍脓毒症的24.4%,ICU死亡率达52.3%。

该系统综述与Meta分析检索了2000年1月至2018年3月的MEDLINE、Embase和Global Index Medicus,纳入51项研究(22项来自中低收入国家),其中28项在ICU、13项在新生儿ICU、10项为全院范围。医院获得性脓毒症占所有医院治疗脓毒症病例的23.6%(95%CI 17-31.8%);在ICU中,24.4%(95%CI 16.7-34.2%)的器官功能障碍脓毒症为ICU获得性,48.7%(95%CI 38.3-59.3%)为医院起源。ICU医院获得性脓毒症合并器官功能障碍的合并发病率为每1000例患者56.5例(95%CI 35-90.2),ICU死亡率52.3%(95%CI 43.4-61.1%)。研究间异质性显著,提示医院获得性脓毒症负担重,尤其在ICU。

要点

  • 医院获得性脓毒症占所有医院治疗脓毒症病例的23.6%(95%CI 17-31.8%),ICU中48.7%(95%CI 38.3-59.3%)的脓毒症为医院起源。
  • ICU中24.4%(95%CI 16.7-34.2%)的器官功能障碍脓毒症为ICU获得性。
  • ICU医院获得性脓毒症合并器官功能障碍的合并发病率为每1000例患者56.5例(95%CI 35-90.2),新生儿ICU尤其高。
  • ICU医院获得性脓毒症合并器官功能障碍的死亡率为52.3%(95%CI 43.4-61.1%)。
  • 研究间异质性显著;ICU研究的偏倚风险为低至中等,全院和新生儿ICU研究为中等至高度。

适用人群与场景

  • 全院范围或ICU(包括新生儿ICU)开展的、报告医院获得性和ICU获得性脓毒症发病率/患病率及社区与医院/ICU起源比例的研究。

研究设计与关键结果

  • 系统综述与Meta分析纳入51项研究(22项来自中低收入国家;28项在ICU、13项在新生儿ICU、10项为全院范围),检索MEDLINE、Embase和Global Index Medicus(2000年1月至2018年3月)。
  • 医院获得性脓毒症占所有医院治疗脓毒症病例的23.6%(95%CI 17-31.8%,范围16-36.4%)。
  • ICU中,24.4%(95%CI 16.7-34.2%,范围10.3-42.5%)的器官功能障碍脓毒症为ICU获得性,48.7%(95%CI 38.3-59.3%,范围18.7-69.4%)为医院起源。
  • 全院医院获得性脓毒症合并器官功能障碍的合并发病率为每1000例患者9.3例(95%CI 7.3-11.9,范围2-20.6);ICU为每1000例患者56.5例(95%CI 35-90.2,范围9.2-254.4),新生儿ICU尤其高。
  • ICU医院获得性脓毒症合并器官功能障碍的死亡率为52.3%(95%CI 43.4-61.1%,范围30.1-64.6%)。
  • 研究间异质性显著;ICU研究的偏倚风险为低至中等,全院和新生儿ICU研究为中等至高度。

证据类型、等级与局限

  • 证据类型:系统综述与随机效应Meta分析。
  • 局限:研究间异质性显著;全院和新生儿ICU研究的偏倚风险为中等至高度。

对床旁实践的改变

  • 作者认为医院获得性脓毒症具有重大公共卫生意义,ICU负担尤其高,迫切需要改进全球和地方感染预防与管理策略的实施,以降低住院患者中的高负担。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Sepsis is recognized as a global public health problem, but the proportion due to hospital-acquired infections remains unclear. We aimed to summarize the epidemiological evidence related to the burden of hospital-acquired (HA) and ICU-acquired (ICU-A) sepsis.

METHODS: We searched MEDLINE, Embase and the Global Index Medicus from 01/2000 to 03/2018. We included studies conducted hospital-wide or in intensive care units (ICUs), including neonatal units (NICUs), with data on the incidence/prevalence of HA and ICU-A sepsis and the proportion of community and hospital/ICU origin. We did random-effects meta-analyses to obtain pooled estimates; inter-study heterogeneity and risk of bias were assessed.

RESULTS: Of the 13,239 studies identified, 51 met the inclusion criteria; 22 were from low- and middle-income countries. Twenty-eight studies were conducted in ICUs, 13 in NICUs, and ten hospital-wide. The proportion of HA sepsis among all hospital-treated sepsis cases was 23.6% (95% CI 17-31.8%, range 16-36.4%). In the ICU, 24.4% (95% CI 16.7-34.2%, range 10.3-42.5%) of cases of sepsis with organ dysfunction were acquired during ICU stay and 48.7% (95% CI 38.3-59.3%, range 18.7-69.4%) had a hospital origin. The pooled hospital incidence of HA sepsis with organ dysfunction per 1000 patients was 9.3 (95% CI 7.3-11.9, range 2-20.6)). In the ICU, the pooled incidence of HA sepsis with organ dysfunction per 1000 patients was 56.5 (95% CI 35-90.2, range 9.2-254.4) and it was particularly high in NICUs. Mortality of ICU patients with HA sepsis with organ dysfunction was 52.3% (95% CI 43.4-61.1%, range 30.1-64.6%). There was a significant inter-study heterogeneity. Risk of bias was low to moderate in ICU-based studies and moderate to high in hospital-wide and NICU studies.

CONCLUSION: HA sepsis is of major public health importance, and the burden is particularly high in ICUs. There is an urgent need to improve the implementation of global and local infection prevention and management strategies to reduce its high burden among hospitalized patients.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Markwart R, Saito H, Harder T, et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med. 2020. PMID: 32591853. doi:10.1007/s00134-020-06106-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。